• ISRIB Reverses Inflammation-Driven Accelerated Memory Loss i

  2026-06-24

  This study demonstrates that systemic inflammation accelerates forgetting of recognition memory in mice via integrated stress response (ISR) activation, and that pharmacological inhibition of the ISR with ISRIB can restore normal memory retention. The findings clarify a mechanistic link between neuroinflammation, ISR signaling, and cognitive deficits, providing a new experimental framework for memory research in neurodegenerative and inflammatory disease models.

• PPT (Propyl Pyrazole Triol): Unlocking ERα-Selective Assays

  2026-06-23

  Explore how PPT (Propyl Pyrazole Triol) empowers researchers to dissect ERα-mediated signaling with unprecedented selectivity. This article uniquely connects PPT’s molecular pharmacology to advanced biomarker assay design in cancer research.

• Dual-Action Inhibitors Promote p38α MAPK Dephosphorylation

  2026-06-23

  The referenced study uncovers that certain kinase inhibitors not only block p38α MAPK activity but also facilitate its dephosphorylation by stabilizing a conformation more accessible to phosphatases. This dual-action mechanism represents a significant advance for designing more effective and selective inhibitors targeting inflammation and cell signaling.

• Olaparib (AZD2281): Protocols and Advances in DNA Damage Res

  2026-06-22

  Olaparib (AZD2281) from APExBIO empowers researchers to dissect DNA repair vulnerabilities and optimize targeted therapies in BRCA-deficient and homologous recombination-impaired cancer models. Discover protocol-ready workflows, troubleshooting insights, and practical guidance to enhance assay reproducibility and translational relevance in DNA damage response and tumor radiosensitization studies.

• Gut-Brain Cholinergic Signaling in B. fragilis Seizure Contr

  2026-06-22

  Jia et al. reveal that Bacteroides fragilis suppresses seizures through activation of gut-brain cholinergic signaling, specifically engaging colonic ChAT+ cells and vagal pathways. Their translational approach provides mechanistic insight into microbiota-neural circuit interactions, highlighting new therapeutic avenues for pediatric refractory epilepsy.

• VX-745: Applied Use-Cases for Selective p38α MAPK Inhibition

  2026-06-21

  VX-745 stands out as a highly selective p38α MAPK inhibitor, enabling researchers to precisely study cytokine signaling in inflammation, cancer, and aging models. This article details advanced workflows, troubleshooting strategies, and the unique dual-action mechanism revealed by structural studies—empowering laboratories to maximize the reproducibility and impact of their kinase pathway research.

• Immunoproteasome Activation Enables TRIM5α Restriction of HI

  2026-06-20

  This study reveals that type I interferon (IFNα) stimulation of the immunoproteasome reprograms human TRIM5α, a previously weak HIV-1 restriction factor, to effectively inhibit early stages of HIV-1 infection. The findings shed light on a novel mechanism of innate antiviral defense and highlight immunoproteasome-dependent regulation as a key determinant in TRIM5α-mediated viral restriction.

• TPCA-1: Optimizing IKK-2 Inhibitor Workflows in Inflammation

  2026-06-19

  TPCA-1 empowers precise dissection of NF-κB-driven inflammation with robust selectivity, supporting reproducible in vitro and in vivo results. Learn how cutting-edge workflows harness this IKK-2 inhibitor to accelerate cytokine modulation assays, troubleshoot common pitfalls, and enable translational insights in rheumatoid arthritis and acute kidney injury models.

• Exosomal HMGB1 Drives Endothelial Injury in Lupus Nephritis

  2026-06-19

  This paper demonstrates that podocyte-derived exosomes enriched with HMGB1 mediate glomerular endothelial cell injury in lupus nephritis (LN) by promoting TRIM27 expression. The findings reveal a critical exosome-dependent pathway in LN pathogenesis and validate the use of exosome release inhibitors for dissecting intercellular kidney injury mechanisms.

• PAD4-IN-2 TFA: Tumor-Selective PAD4 Inhibition and Immune Mo

  2026-06-18

  Discover how PAD4-IN-2 TFA enables precise PAD4 inhibition and immune microenvironment modulation in cancer research. This deep-dive unpacks its targeted mechanism, assay guidance, and safety profile, offering distinct insights beyond existing overviews.

• Midecamycin: Precision Targeting of Bacterial Protein Synthe

  2026-06-18

  Explore how Midecamycin, a 16-membered acetoxy-substituted macrolide antibiotic, enables precise inhibition of bacterial protein synthesis for advanced microbiology studies. This article uniquely bridges structural pharmacology, resistance mechanisms, and translational assay design to elevate research workflows.

• Gut-Brain Cholinergic Signaling and Seizure Control by B. fr

  2026-06-17

  Jia et al. demonstrate that Bacteroides fragilis suppresses seizures via activation of gut-brain cholinergic signaling, specifically enhancing vagal transmission and involving colonic ChAT+ cells. This mechanistic insight establishes a translational foundation for microbiota-based therapies in pediatric refractory epilepsy.

• Hoechst 33258: Molecular Insights and Innovations in DNA Sta

  2026-06-17

  Explore the molecular mechanism and advanced applications of Hoechst 33258, a leading bis-benzimide DNA stain. Discover how new biophysical research is shaping DNA assay strategies for tumor heterogeneity and cell mechanics.

• Otilonium Bromide in Advanced Cholinergic Pathway Modulation

  2026-06-16

  Explore Otilonium Bromide as an antimuscarinic agent for cutting-edge cholinergic signaling pathway research. This article delivers a scientific deep dive into its mechanistic distinctions, protocol optimization, and relevance for next-generation neuroscience and smooth muscle studies.

• HotStart 2X Green qPCR Master Mix: Precision in Gene Quantif

  2026-06-16

  Unlock ultra-specific, high-sensitivity real-time PCR gene expression analysis with HotStart™ 2X Green qPCR Master Mix. This APExBIO innovation streamlines workflows, enables robust non-invasive genotyping, and delivers unrivaled reproducibility—even in challenging contexts like cephalopod research or RNA-seq validation.

16286 records 1/1086 page Next 12345 下5页 Last page